Literature DB >> 23356892

Novel ATP2A2 mutations in a large sample of individuals with Darier disease.

Elaine K Green1, Katherine Gordon-Smith, Susan M Burge, Detelina Grozeva, Colin S Munro, Sherine Tavadia, Lisa Jones, Nicholoas Craddock.   

Abstract

Darier disease (DD) is a rare autosomal dominantly inherited skin disorder caused by mutations in ATP2A2, which is expressed in both the skin and the brain and encodes for SERCA2. We have screened the coding regions of ATP2A2 in a total of 95 unrelated individuals with DD to identify the pathogenic mutations. We identified 66 potentially pathogenic mutations in ATP2A2 for 74 of the 95 individuals with DD of which 45 (68%) are thought to be novel. Forty-nine (74%) are unique to an individual and 17 (26%) were found in more than one individual or overlap with previously identified variants. The results suggest that mutations in ATP2A2 may not be as family-specific as first thought. The spectrum of mutations identified will inform understanding of the pathogenesis of DD.
© 2013 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356892     DOI: 10.1111/1346-8138.12082

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  Ionic leakage underlies a gain-of-function effect of dominant disease mutations affecting diverse P-type ATPases.

Authors:  Maki Kaneko; Bela S Desai; Boaz Cook
Journal:  Nat Genet       Date:  2013-12-15       Impact factor: 38.330

Review 2.  [Palmoplantar dermatoses: when should genes be considered?].

Authors:  C Seebode; S Schiller; S Emmert; K Giehl
Journal:  Hautarzt       Date:  2014-06       Impact factor: 0.751

3.  Identification of two novel Darier disease‑associated mutations in the ATP2A2 gene.

Authors:  Libao Zheng; Huili Jiang; Qin Mei; Bin Chen
Journal:  Mol Med Rep       Date:  2015-04-09       Impact factor: 2.952

4.  Novel mutations in Darier disease and association to self-reported disease severity.

Authors:  Ivone U S Leong; Alexander Stuckey; Tara Ahanian; Martin Cederlöf; Jakob D Wikstrom
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.